Filtered Product News
Bio-Rad Launches High-Precision Vericheck ddPCR Empty-Full Capsid Kit to Advance Development of Safe and Effective Gene Therapies
Vericheck ddPCR Empty-Full Capsid Kit Combines Measuring Viral Titer and Capsid Titer, Providing a High-Precision Assessment for Critical Quality Attributes of Both Protein and DNA in Droplets
Bio-Rad Launches Annexin V StarBright Conjugates for Apoptosis Detection via Flow Cytometry
Annexin V StarBrightTM Conjugates Offer Increased Choice and Flexibility for Apoptosis Detection in Conventional and Full Spectrum Flow Cytometry
Bio-Rad's Study Demonstrating Utility of its SpyLock Technology for Fast Generation and Screening of Bispecific Antibodies Published in Nature Communications
Study Describes Method to Successfully Modify the Functional Activity of SpyCatcher Protein for the Rapid Generation and High-Throughput Screening of Bispecific Antibodies
Bio-Rad Adds Rapid Bispecific Antibody Prototyping and Screening Services to Pioneer Antibody Discovery Platform
New Service Enables Identification of Bispecific Antibody Candidates Accelerating Drug Development.
Bio-Rad Outlines Its Advances Leveraging Droplet Digital PCR in Biopharma and Translational Research Sectors
Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024
Bio-Rad Launches ChemiDoc Go Imaging System for Highly Sensitive Benchtop Gel and Western Blot Imaging
Compact System Uses CMOS Digital Imaging and Is Compatible with Chemiluminescence and Fluorescence Detection and Stain-Free Technology
Bio-Rad Launches Celselect Slides Version 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research
New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream Applications
Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development
Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials
Bio-Rad Launches ddSEQ™ Single-Cell 3’ RNA-Seq Kit for single cell gene expression
ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research
Bio-Rad Launches Three StarBright Red Dyes and Expands Range of Antibody Markers Conjugated to StarBright Violet Dyes to Enhance Immunology Research
Bio-Rad's Range of StarBright Dyes Conjugated to Highly Validated Antibodies Now Totals 32 Dyes, Providing Greater Choice and Flexibility for Conventional and Full-Spectrum Flow Cytometry in Immunology Research.
Bio-Rad Announces Collaboration Agreement with Oncocyte to Commercialize Transplant Monitoring with Droplet Digital PCR
Collaboration Aims to Provide Researchers Cutting-Edge Tools to Enable Transformational Monitoring of Key Biomarkers in Solid Tissue Transplants
Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR
Collaboration Aims to Grow Clinical Evidence Supporting the use of Bio-Rad’s ddPCR™ Technology for Molecular Residual Disease Monitoring of Patients across a Range of Solid Tumor Types